Scientists have recently found that GLP-1 receptors are also connected to parts of the brain responsible for motivation and reward, which are a key to understanding substance use disorder
PubMed laboratory research record [PMID: 33439580] PubMed record related to this compound for laboratory literature review
TRT Nations blog covers the metabolic protection aspect of this treatment in greater detail
*Correspondence: Antonio Di Sabatino, [email protected] This article was submitted to Gastroenterology, a section of the journal Frontiers in Medicine Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Recommend the following RYBELSUS (formulation R2) dosage to reduce the risk of gastrointestinal adverse reactions [see Warnings and Precautions (5.6), Adverse Reactions (6.1)]: Starting Dosage (Initiation Phase) (Days 1 through 30): The recommended starting dosage is 1.5 mg orally once daily (this dosage is not effective for glycemic control)
According to clinical trials, approximately 40% of patients experienced nausea, while around 20% reported vomiting